Sep 9, 2026 04:30PM
Jul 7, 2026 04:23AM
Jul 6, 2026 06:20PM
May 19, 2026 08:06AM
May 19, 2026 08:00AM
May 19, 2026 08:00AM
May 19, 2026 08:00AM /C O R R E C T I O N -- InMed Pharmaceuticals/
Mar 23, 2026 07:32AM
Mar 23, 2026 07:30AM
Mar 9, 2026 07:30AM
Feb 11, 2026 05:23PM
Dec 12, 2025 05:31PM
Nov 18, 2025 07:32AM
Nov 18, 2025 07:30AM InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901
Nov 6, 2025 04:51PM
Jan 10, 2023 07:32AM
Jan 10, 2023 07:30AM
Nov 11, 2022 06:51PM
Nov 11, 2022 06:51PM
Sep 23, 2022 12:29PM
Sep 23, 2022 12:29PM InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
May 13, 2022 07:30AM
May 13, 2022 07:30AM
Feb 15, 2022 05:40AM
Feb 14, 2022 07:34PM
Feb 14, 2022 07:34PM
Jan 5, 2022 07:30AM
Jan 5, 2022 07:30AM InMed Issues Annual Letter to Shareholders Highlighting Key Accomplishments from 2021 and Providing 2022 Outlook
Nov 10, 2021 07:30AM
Nov 10, 2021 07:30AM
Apr 28, 2021 07:52AM
Apr 28, 2021 07:30AM

335,190 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All